Recent Insider Activity Suggests Potential Gains for Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc’s recent filing unveils that its CEO and President Shukla Sath unloaded Company’s shares for reported $65385.0 on Feb 05 ’24. In the deal valued at $1.45 per share,45,093 shares were sold. As a result of this transaction, Shukla Sath now holds 1,176,007 shares worth roughly $2.12 million. Then, Mahadevia Ankit sold 63,795 […]